Answers are grounded in this paper and cite their sources.
Available evidence seems to exclude any overall harmful effect of metformin on cardiovascular risk, suggesting a possible benefit versus placebo/no treatment. The observed detrimental effect of the combination with sulphonylureas deserves further investigation.
No takes yet. Share an insight, caveat, or question.
Lamanna et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: